HuGE Literature Finder
Records
1
-
30
| Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant. NPJ breast cancer 2022 Jun 8 (1): 71. Correia Lizelle, Magno Ramiro, Xavier Joana M, de Almeida Bernardo P, Duarte Isabel, Esteves Filipa, Ghezzo Marinella, Eldridge Matthew, Sun Chong, Bosma Astrid, Mittempergher Lorenza, Marreiros Ana, Bernards Rene, Caldas Carlos, Chin Suet-Feung, Maia Ana-Tere |
| Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology 2022 Jun . Tsang Julia Y, Shao Yan, Poon Ivan K, Ni Yun-Bi, Kwan Johnny S, Chow Chit, Shea Ka-Ho, Tse Gary |
| Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures. Nature communications 2022 Jun 13 (1): 3254. Georgeson Peter, Harrison Tabitha A, Pope Bernard J, Zaidi Syed H, Qu Conghui, Steinfelder Robert S, Lin Yi, Joo Jihoon E, Mahmood Khalid, Clendenning Mark, Walker Romy, Amitay Efrat L, Berndt Sonja I, Brenner Hermann, Campbell Peter T, Cao Yin, Chan Andrew T, Chang-Claude Jenny, Doheny Kimberly F, Drew David A, Figueiredo Jane C, French Amy J, Gallinger Steven, Giannakis Marios, Giles Graham G, Gsur Andrea, Gunter Marc J, Hoffmeister Michael, Hsu Li, Huang Wen-Yi, Limburg Paul, Manson JoAnn E, Moreno Victor, Nassir Rami, Nowak Jonathan A, Obón-Santacana Mireia, Ogino Shuji, Phipps Amanda I, Potter John D, Schoen Robert E, Sun Wei, Toland Amanda E, Trinh Quang M, Ugai Tomotaka, Macrae Finlay A, Rosty Christophe, Hudson Thomas J, Jenkins Mark A, Thibodeau Stephen N, Winship Ingrid M, Peters Ulrike, Buchanan Daniel |
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer. Targeted oncology 2022 Jun . Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H |
| Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing. World journal of clinical cases 2022 May 10 (15): 4761-4775. Zeng Hui-Hui, Yang Ze, Qiu Ye-Bei, Bashir Shoaib, Li Yin, Xu Me |
| Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status. Journal of cancer research and clinical oncology 2022 May . Jenniskens Josien C A, Offermans Kelly, Simons Colinda C J M, Samarska Iryna, Fazzi Gregorio E, van der Meer Jaleesa R M, Smits Kim M, Schouten Leo J, Weijenberg Matty P, Grabsch Heike I, van den Brandt Piet |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 May . Cristofanilli Massimo, Rugo Hope S, Im Seock-Ah, Slamon Dennis J, Harbeck Nadia, Bondarenko Igor, Masuda Norikazu, Colleoni Marco, DeMichele Angela, Loi Sherene, Iwata Hiroji, O'Leary Ben, André Fabrice, Loibl Sibylle, Bananis Eustratios, Liu Yuan, Huang Xin, Kim Sindy, Lechuga Frean Maria Jose, Turner Nicholas |
| The molecular landscape of pancreatobiliary cancers for novel targeted therapies from real-world genomic profiling. Journal of the National Cancer Institute 2022 May . Umemoto Kumiko, Yamamoto Hiroyuki, Oikawa Ritsuko, Takeda Hiroyuki, Doi Ayako, Horie Yoshiki, Arai Hiroyuki, Ogura Takashi, Mizukami Takuro, Izawa Naoki, Moore Jay A, Sokol Ethan S, Sunakawa |
| PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer. NPJ breast cancer 2022 Feb 8 (1): 24. Migliaccio Ilenia, Paoli Marta, Risi Emanuela, Biagioni Chiara, Biganzoli Laura, Benelli Matteo, Malorni Lu |
| The Genomics of Colorectal Cancer in Populations with African and European Ancestry. Cancer discovery 2022 Feb . Myer Parvathi A, Lee Jessica K, Madison Russell W, Pradhan Kith, Newberg Justin Y, Isasi Carmen R, Klempner Samuel J, Frampton Garrett M, Ross Jeffrey S, Venstrom Jeffrey M, Schrock Alexa B, Das Sudipto, Augenlicht Leonard, Verma Amit, Greally John M, Raj Srilakshmi M, Goel Sanjay, Ali Siraj |
| Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing. Genes 2022 Jan 13 (2): . Qiu Ling, Feng Hao, Yu Hailin, Li Ming, You Yana, Zhu Shurong, Yang Wenting, Jiang Hua, Wu X |
| Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location. International journal of clinical oncology 2022 Jan . Chen Yongle, Chen Zexian, Huang Juanni, Hu Jiancong, He Xiaowen, Lan Ping, He Xiaoshe |
| Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance. Gynecologic oncology 2022 Jan . Kashofer Karl, Regauer Sigrid, Reich Olaf, Petru Edgar, Winter El |
| Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland) 2022 Jan 62 52-60. Lee Soohyeon, Park Kyunghee, Kim Gun Min, Jung Kyung Hae, Kang Seok Yun, Park In Hae, Kim Jee Hyun, Ahn Hee Kyung, Park Woong-Yang, Im Seock-Ah, Park Yeon H |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma. British journal of cancer 2022 Jan . Ye Shuang, Li Qin, Wu Yutuan, Jiang Wei, Zhou Shuling, Zhou Xiaoyan, Yang Wentao, Tu Xiaoyu, Shan Boer, Huang Shenglin, Yang Huiju |
| Colorectal Cancer Genomics by Genetic Ancestry. Cancer discovery 2022 05 12 (5): 1187-1188. Eng Cathy, Holowatyj Andreana |
| Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer. PloS one 2022 17 (6): e0267090. Marbun Vania Myralda Giamour, Erlina Linda, Lalisang Toar Jean Mauri |
| Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
| Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. Molecular medicine (Cambridge, Mass.) 2022 05 28 (1): 55. Zhou Zihan, Li Peifeng, Zhang Xianbin, Xu Juan, Xu Jin, Yu Shui, Wang Dongqing, Dong Wei, Cao Xiujuan, Yan Hongjiang, Sun Mingping, Ding Xiuping, Xing Jun, Zhang Peng, Zhai Limin, Fan Tingyong, Tian Shiyu, Yang Xinhua, Hu M |
| Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population. BMC medical genomics 2022 07 15 (1): 146. Huang Qingfeng, Zhou Yang, Wang Bowen, Zhao Yi, Zhang Fengxia, Ding Bow |
| Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer. Scientific reports 2022 02 12 (1): 2767. Ogawa Makiko, Tanaka Atsushi, Namba Kei, Shia Jinru, Wang Julia Y, Roehrl Michael H |
| Clinical and genomic features of SPOP-mutant prostate cancer. The Prostate 2021 Nov . Nakazawa Mari, Fang Mike, H Marshall Catherine, Lotan Tamara L, Isaacsson Velho Pedro, Antonarakis Emmanuel |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. Balkan medical journal 2021 Nov 38 (6): 382-391. Kahraman Çetin Nesibe, Erdo?du ?brahim Halil, Bozkurt Emin, Meteo?lu ?brah |
| Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype. PLoS genetics 2021 Nov 17 (11): e1009876. Madsen Ralitsa R, Erickson Emily C, Rueda Oscar M, Robin Xavier, Caldas Carlos, Toker Alex, Semple Robert K, Vanhaesebroeck Ba |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| A biomarker study in Peruvian males with breast cancer. World journal of clinical oncology 2021 Oct 12 (10): 926-934. Castaneda Carlos A, Castillo Miluska, Bernabe Luis A, Sanchez Joselyn, Torres Ebert, Suarez Nancy, Tello Katherine, Fuentes Hugo, Dunstan Jorge, De La Cruz Miguel, Cotrina Jose Manuel, Abugattas Julio, Guerra Henry, Gomez Henry |
| Cancer gene related characterization of patterns and point of recurrence after resection of colorectal liver metastases. Annals of translational medicine 2021 Sep 9 (17): 1372. Lang Hauke, Baumgart Janine, Roth Wilfried, Moehler Markus, Kloth Micha |
| Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer. Cancer genomics & proteomics 0 19 (4): 464-476. Stella Stefania, Vitale Silvia Rita, Massimino Michele, Motta Gianmarco, Longhitano Claudio, Lanzafame Katia, Martorana Federica, Fazzari Carmine, Vecchio Giada Maria, Tirrò Elena, Inzerilli Nicola, Carciotto Rosaria, Manzella Livia, Caruso Michele, Vigneri Pao |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: